Post-polycythemia Vera Myelofibrosis (Post-PV MF)
7 clinical trials · Condition
◉ Watch Post-polycythemia Vera Myelofibrosis (Post-PV MF)
| Record | Firm | Date |
|---|---|---|
| Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis (NCT07340138) | Novartis Pharmaceuticals | 2026-04-15 |
| MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) (NCT07362225) | MPN Research Foundation | 2025-09-26 |
| Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis (NCT04878003) | Kartos Therapeutics, Inc. | 2021-04-13 |
| Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis (NCT04217993) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2020-01-07 |
| Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib (NCT03935555) | Samus Therapeutics, Inc. | 2019-08-12 |
| Extended Access of Momelotinib in Adults With Myelofibrosis (NCT03441113) | GlaxoSmithKline | 2018-05-03 |
Track Post-polycythemia Vera Myelofibrosis (Post-PV MF) automatically
Every clearance here is in the API, with alerts when new ones post.